Medicament combination for curing respiratory diseases and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for respiratory diseases and compositions, applied in the field of medicine, to achieve significant effects, improve symptoms, and improve symptoms of wheezing and shortness of breath
Inactive Publication Date: 2009-09-16
天津中医药大学第二附属医院
View PDF0 Cites 20 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there is currently no clinically available Chinese patent medicine specifically for the treatment of stable COPD, chronic persistent bronchial asthma, chronic remission of bronchiectasis, and chronic protracted pulmonary fibrosis. very important
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0048] Example 1. Preparation of pharmaceutical composition
[0049] Accurately weigh 200g Codonopsis, 200g Rehmannia glutinosa, 200g Cornus, 60g Roasted Ephedra, 200g Angelica, 200g Red Peony, 100g Scutellaria, 100g Tangerine Peel, 100g Aster, 60g Licorice, and decocted twice with water, 2 each time Hours, the first time is 10 times the amount of water, the second time is 8 times the amount of water, filtered, the combined filtrate is concentrated to a clear cream with a relative density of 1.30~1.32 (55°C), dried (drying temperature is 60°C), and crushed into Fine powder, sieved, added with appropriate amount of lactose, mixed, and dried into granules to obtain the composition of the present invention, called "Bufei granules" (represented by the code "BFKL", the same below), 512g. Lot number: BFKL-1.
Embodiment 2
[0050] Example 2. Preparation of pharmaceutical composition
[0051] Accurately weigh 180g of Codonopsis, 180g of Rehmannia glutinosa, 180g of cornus, 80g of roasted ephedra, 220g of angelica, 220g of red peony, 120g of scutellaria, 120g of tangerine peel, 80g of aster, 40g of licorice and ten medicinal materials. Hours, the first time is 10 times the amount of water, the second time is 8 times the amount of water, filtered, the combined filtrate is concentrated to a clear cream with a relative density of 1.30~1.32 (55°C), dried (drying temperature is 60°C), and crushed into The fine powder is sieved, added with an appropriate amount of lactose, mixed well, and dried into granules to obtain 518 g of lung-buying particles, which is the pharmaceutical composition for the lung-buying of the present invention. Lot number: BFKL-2.
Embodiment 3
[0052] Example 3. Preparation of pharmaceutical composition
[0053] Accurately weigh 220g of Codonopsis, 220g of Rehmannia glutinosa, 220g of cornus, 40g of roasted ephedra, 180g of angelica, 180g of red peony, 120g of scutellaria, 80g of tangerine peel, 80g of aster, 80g of licorice and ten medicinal materials. Hours, the first time is 10 times the amount of water, the second time is 8 times the amount of water, filtered, the combined filtrate is concentrated to a clear cream with a relative density of 1.30~1.32 (55°C), dried (drying temperature is 60°C), and crushed into Fine powder, sieved, added with appropriate amount of lactose, mixed well, and dried into granules to obtain 540 g of lung-buying granules to obtain the lung-buying pharmaceutical composition of the present invention. Lot number: BFKL-3.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicament combination for curing respiratory diseases and the application thereof. The effective components of the medicament combination are prepared by the following components: 1) the medicament for tonifying middle-Jiao and Qi, strengthening spleen and tonifying lung is selected from Dangshen, Astragalus root, ginseng, radix pseudostellariae and American ginseng; 2) the medicament for nourishing yin, supplementing blood, tonifying the kidney and controlling the nocturnal emission is selected from prepared rhizome of rehmannia, radix rehmanniae and Chinese angelica; 3) the medicament for tonifying the liver and kidney, supporting the healthy energy and stopping Asthma is selected from dogwood fruit, fleece-flower root, shizandra berry, human placentae and gecko; 4) the medicament for relieving exterior syndrome, dispersing cold, freeing lung and relieving asthma is selected from baked Chinese ephedra and ginkgo; 5) the medicament for clearing heat, drying damp, purging intense heat and detonicating is selected from Baikal skullcap root, golden buckwheat rhizome and Chinese angelica; 6) the medicament for regulating the flow of Qi, strengthening the spleen, removing dampness and reducing phlegm is selected from dried orange peel, green tangerine orange peel, bitter orange and dried tangerine peel; 7) the medicament for moistening lung, depressing Qi, dissolving phlegm and relieving the cough is selected from tatarian aster root, radix stemonae and common coltsfoot flower; 8) the medicament for removing pathogenic heat from blood, promoting blood circulation and removing blood stasis is selected from root of herbaceous peony with bark, root of red rooted salvia and radix curcumae; and 9) liquorice; licorice.
Description
Technical field [0001] The invention belongs to the field of medical technology, and specifically relates to a pharmaceutical composition for treating respiratory diseases and its use. Background technique [0002] Chronic obstructive pulmonary diseases (COPD) is a disease with the characteristics of airflow limitation. The airflow limitation is not completely reversible and develops progressively. It is related to the abnormal inflammatory response of the lungs to harmful gases or harmful particles. . COPD mainly affects the lungs, but it can also cause systemic (or extra-pulmonary) adverse effects. Because of its large number of patients, high mortality, and heavy social and economic burden, it has become an important public health problem. COPD currently ranks the 4th cause of death in the world. The World Bank / World Health Organization announced that by 2020, COPD will rank 5th in the world's economic burden of disease. In our country, COPD is also an important chronic respir...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more